48,466
edits
Difference between revisions of "Uterus"
Jump to navigation
Jump to search
→BRCA carrier
| (One intermediate revision by the same user not shown) | |||
| Line 157: | Line 157: | ||
*STIC ~ 6.2% | *STIC ~ 6.2% | ||
===Grossing=== | |||
*In prophylatic procedures, the ovaries and tubes, endometrium, and lower uterine segment should all be [[submitted in total]].<ref name=pmid24495259>{{Cite journal | last1 = Downes | first1 = MR. | last2 = Allo | first2 = G. | last3 = McCluggage | first3 = WG. | last4 = Sy | first4 = K. | last5 = Ferguson | first5 = SE. | last6 = Aronson | first6 = M. | last7 = Pollett | first7 = A. | last8 = Gallinger | first8 = S. | last9 = Bilbily | first9 = E. | title = Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing. | journal = Histopathology | volume = 65 | issue = 2 | pages = 228-39 | month = Aug | year = 2014 | doi = 10.1111/his.12386 | PMID = 24495259 }}</ref> | |||
===Microscopic=== | ===Microscopic=== | ||
| Line 162: | Line 164: | ||
*Early [[serous carcinoma]] of the fallopian tube or ovary. | *Early [[serous carcinoma]] of the fallopian tube or ovary. | ||
*[[STIC]]. | *[[STIC]]. | ||
===IHC=== | |||
*p53 -ve. | |||
*p16 -ve. | |||
*Ki-67 low. | |||
===Sign out=== | ===Sign out=== | ||